ACPT-II

Discontinued Product

1112 has been discontinued.

View all Non-selective Metabotropic Glutamate products.
说明: Competitive mGlu receptor antagonist
化学名: (1R,3R,4S)-1-Aminocyclopentane-1,3,4-tricarboxylic acid
说明书
引用文献 (2)
评论
文献 (2)

生物活性 for ACPT-II

ACPT-II is a competitive metabotropic receptor antagonist (KB values are 115, 88 and 77 μM at mGlu1a, mGlu2 and mGlu4a respectively).

许可信息

Sold with the permission of the CNRS

技术数据 for ACPT-II

分子量 217.18
公式 C8H11NO6
储存 Desiccate at -20°C
CAS Number 195209-04-2
PubChem ID 6604820
InChI Key FERIKTBTNCSGJS-OBLUMXEWSA-N
Smiles N[C@]1([C@@](O)=O)C[C@H]([C@](O)=O)[C@H]([C@@](O)=O)C1

上方提供的技术数据仅供参考。批次相关数据请参见分析证书。

Tocris products are intended for laboratory research use only, unless stated otherwise.

关键词: ACPT-II, ACPT-II supplier, Competitive, receptor, antagonists, Non-Selective, Receptors, Metabotropic, Glutamate, Non-selective, mGlu, 1112, Tocris Bioscience

2 篇 ACPT-II 的引用文献

引用文献是使用了 Tocris 产品的出版物。 ACPT-II 的部分引用包括:

Casado et al (2000) Presynaptic N-MthD.-aspartate receptors at the parallel fiber-Purkinje cell synapse. Int J Mol Sci 97 11593 PMID: 11016958

Scholler (2017) HTS-compatible FRET-based conformational sensors clarify membrane receptor activation. Nat Chem Biol 13 372 PMID: 28135236


ACPT-II 的评论

目前没有该产品的评论。 Be the first to review ACPT-II and earn rewards!

Have you used ACPT-II?

Submit a review and receive an Amazon gift card.

$50/€35/£30/$50CAN/¥300 Yuan/¥5000 Yen for first to review with an image

$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image

$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image

Submit a Review

该领域的文献

Tocris offers the following scientific literature in this area to showcase our products. We invite you to request* your copy today!

*请注意,Tocris 仅会向正规科研企业/机构地址发送文献。


Metabotropic Glutamate Receptors Scientific Review

Metabotropic Glutamate Receptors Scientific Review

Written by Francine Acher, this review discusses the pharmacology and therapeutic potential of mGlu receptors, and the compounds acting upon them; compounds available from Tocris are listed.

Parkinson's Disease Poster

Parkinson's Disease Poster

Parkinson's disease (PD) causes chronic disability and is the second most common neurodegenerative condition. This poster outlines the neurobiology of the disease, as well as highlighting current therapeutic treatments for symptomatic PD, and emerging therapeutic strategies to delay PD onset and progression.